A salophen-type macrocyclic Schiff base ligand and its metal complexes: exploring in vitro anticancer efficacy via in silico topoisomerase IIβ enzyme targeting
Dalton Transactions · 2025 · 54 (26) · 10358-10369
DOI: 10.1039/d5dt00993f ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2025. Verfasst von Monika Yadav und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology Kurukshetra-136119, Haryana, India. jkkapoor@nitkkr.ac.in. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, DNA Topoisomerases, Type II, Topoisomerase II Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
A salophen-type Schiff-base ligand and its metal complexes have been reported as potent anticancer agents against HepG2 cell line. Molecular interactions in the active site of enzyme topoisomerase IIβ, were also elucidated via molecular docking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Institute of Technology Kurukshetra-136119, Haryana, India. jkkapoor@nitkkr.ac.in.
- Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh-160012, India.
Zitieren
APA
Yadav, M., Yadav, D., Singh, D. P., & Kapoor, J. K. (2025). A salophen-type macrocyclic Schiff base ligand and its metal complexes: exploring in vitro anticancer efficacy via in silico topoisomerase IIβ enzyme targeting. Dalton Transactions, 54(26), 10358-10369. https://doi.org/10.1039/d5dt00993f
Vancouver
Yadav M, Yadav D, Singh DP, Kapoor JK. A salophen-type macrocyclic Schiff base ligand and its metal complexes: exploring in vitro anticancer efficacy via in silico topoisomerase IIβ enzyme targeting. Dalton Transactions. 2025;54(26):10358-10369. doi:10.1039/d5dt00993f
BibTeX
@article{Yadav2025,
author = {Yadav, Monika and Yadav, Deepak and Singh, Dharam Pal and Kapoor, Jitander Kumar},
title = {A salophen-type macrocyclic Schiff base ligand and its metal complexes: exploring in vitro anticancer efficacy via in silico topoisomerase IIβ enzyme targeting},
journal = {Dalton Transactions},
year = {2025},
volume = {54},
number = {26},
pages = {10358--10369},
doi = {10.1039/d5dt00993f}
}
EUVIMED